相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria
Sagar Agarwal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development
Sara C. Humphreys et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Therapeutic siRNA: state of the art
Bo Hu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
Eliane Sardh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters
Diane Ramsden et al.
DRUG METABOLISM AND DISPOSITION (2019)
Discovery of a novel deaminated metabolite of a single-stranded oligonucleotide in vivo by mass spectrometry
Jing Li et al.
BIOANALYSIS (2019)
Oligonucleotide quantification and metabolite profiling by high-resolution and accurate mass spectrometry
Ju Liu et al.
BIOANALYSIS (2019)
Evaluation of electrophoretic mobility shift assay as a method to determine plasma protein binding of siRNA
Carrie Rocca et al.
BIOANALYSIS (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
Advanced siRNA Designs Further Improve In Vivo Performance of GaINAc-siRNA Conjugates
Donald J. Foster et al.
MOLECULAR THERAPY (2018)
Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc-siRNA conjugates
Jayaprakash K. Nair et al.
NUCLEIC ACIDS RESEARCH (2017)
Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins?
Kotaro Nakanishi
WILEY INTERDISCIPLINARY REVIEWS-RNA (2016)
Knocking down disease: a progress report on siRNA therapeutics
Anders Wittrup et al.
NATURE REVIEWS GENETICS (2015)
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
Amy Chan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Acute Hepatic Porphyria
D. Montgomery Bissell et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2015)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
The porphyrias: advances in diagnosis and treatment
Manisha Balwani et al.
BLOOD (2012)
Argonaute2 is the catalytic engine of mammalian RNAi
JD Liu et al.
SCIENCE (2004)
分享论文
